Tea Polyphenols and Their Preventive Measures against Cancer: Current Trends and Directions
Abstract
:1. Introduction
2. Search Approach and Study Choosing
2.1. Search Approach
2.2. Inclusive Criteria
2.3. Exclusion Criteria
3. Mechanistic Studies on the Activities of EGCG against Cancer Cell Lines
4. Studies on Green Tea and Human Cancer
4.1. Breast Cancer
Target Organ | Mechanism of Action | Study Type | Reference |
---|---|---|---|
Breast | Inhibition of cell growth and enzymatic activities, Development of mitochondrial depolarization | In vivo | [38] |
Lung | Decrease in the mRNA and protein levels, Inhibition of tumor growth | In vitro, in vivo | [28,39] |
Colon-rectum | Induction of nuclear translocation, reduction in tumor multiplicity and size | In vitro | [40] |
prostate | Provision of resistance against oxidative stress, Induction of kinase enzyme to inhibit cancerous cell growth | In vitro, in vivo | [41,42] |
Stomach | Stimulation of protein kinase, interference with cell signaling pathways | In vitro, in vivo | [43] |
liver | Reduction in cell inflammation | In vivo | [44] |
Skin | Invasion of melanoma cells, inhibition of melanoma tumor growth | In vitro | [45,46] |
4.2. Lung Cancer
4.3. Colorectal Cancer (CRC)
4.4. Prostate Cancer (PC)
4.5. Stomach/Gastric Cancer
4.6. Liver Cancer
4.7. Skin Cancer
4.8. Pancreatic Cancer
4.9. Oral Cancer or Dental Problems
4.10. Ovarian Cancer
4.11. Bladder Cancer
4.12. Esophageal Cancer
5. Discussion and Limitations
- As green tea is more popular in Asian countries, especially China, Japan, etc., tea consumption is higher in those areas. As a result, most of the epidemiological studies were performed on the people living in that region. As environment is a crucial factor in creating cancer types, epidemiological studies should be performed worldwide to obtain more concrete results [64].
- In a dose-manner way, how much green tea intake could show sufficient efficacy against cancer is still unknown. Studies with a wide range of the population drinking various amounts of tea should be examined and analyzed [51].
- Only observational studies cannot provide proper information about the association between green tea and cancer prevention. Population-based clinical trials should be conducted to be certain about the anti-cancer activity of green tea [54].
- It has been reported that green tea can prevent different types of cancer or can be used as treatment for a while by treating naturally without any side effects. However, how efficacious green tea would be against different sub cancer types is still unknown. Thus, further analysis with various sub-types of cancer could be performed [18].
- It has been reported in a number of literatures that drinking hot green tea may stimulate cancerous cell growth (i.e., stomach or esophageal cancer). Thus, population-based tests with tea at both hot and moderate temperatures should be performed to reach a result [35].
- Several harmful effects on the human body have been reported due to excessive green tea consumption owing to some of its structural components [9].
- ✓ Causing cytotoxicity of liver cells by EGCG
- ✓ Occurrence of oxidative DNA damage in pancreas and liver
- ✓ Causing frequent hyperglycemia in diabetic patients
- ✓ May cause renal failure by offering excessive aluminum to patients
- ✓ Its caffeine content may be malignant for heart disease patients
6. Conclusions and the Following Potentials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Wang, L.-F.; Lee, J.-Y.; Chung, J.-O.; Baik, J.-H.; So, S.; Park, S.-K. Discrimination of teas with different degrees of fermentation by SPME–GC analysis of the characteristic volatile flavour compounds. Food Chem. 2008, 109, 196–206. [Google Scholar] [CrossRef] [PubMed]
- Hu, G.; Zhang, L.; Rong, Y.; Ni, X.; Sun, Y. Downstream carcinogenesis signaling pathways by green tea polyphenols: A translational perspective of chemoprevention and treatment for cancers. Curr. Drug Metab. 2014, 15, 14–22. [Google Scholar] [CrossRef] [PubMed]
- Yuan, J.-M.; Sun, C.; Butler, L.M. Tea and cancer prevention: Epidemiological studies. Pharmacol. Res. 2011, 64, 123–135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xing, L.; Zhang, H.; Qi, R.; Tsao, R.; Mine, Y. Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols. J. Agric. Food Chem. 2019, 67, 1029–1043. [Google Scholar] [CrossRef]
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef]
- Niu, L.; Li, Z.; Fan, W.; Zhong, X.; Peng, M.; Liu, Z. Nano-Strategies for Enhancing the Bioavailability of Tea Polyphenols: Preparation, Applications, and Challenges. Foods 2022, 11, 387. [Google Scholar] [CrossRef]
- Hua, J.; Wang, H.; Yuan, H.; Yin, P.; Wang, J.; Guo, G.; Jiang, Y. New insights into the effect of fermentation temperature and duration on catechins conversion and formation of tea pigments and theasinensins in black tea. J. Sci. Food Agric. 2022, 102, 2750–2760. [Google Scholar] [CrossRef]
- KC, Y.; Parajuli, A.; Khatri, B.B.; Shiwakoti, L.D. Phytochemicals and quality of green and black teas from different clones of tea plant. J. Food Qual. 2020, 2020, 8874271. [Google Scholar] [CrossRef]
- Chacko, S.M.; Thambi, P.T.; Kuttan, R.; Nishigaki, I. Beneficial effects of green tea: A literature review. Chin. Med. 2010, 5, 1–9. [Google Scholar] [CrossRef] [Green Version]
- Chupeerach, C.; Aursalung, A.; Watcharachaisoponsiri, T.; Whanmek, K.; Thiyajai, P.; Yosphan, K.; Sritalahareuthai, V.; Sahasakul, Y.; Santivarangkna, C.; Suttisansanee, U. The effect of steaming and fermentation on nutritive values, antioxidant activities, and inhibitory properties of tea leaves. Foods 2021, 10, 117. [Google Scholar] [CrossRef]
- Yang, Y.; Zhang, T. Antimicrobial activities of tea polyphenol on phytopathogens: A review. Molecules 2019, 24, 816. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Briguglio, G.; Costa, C.; Pollicino, M.; Giambò, F.; Catania, S.; Fenga, C. Polyphenols in cancer prevention: New insights. Int. J. Funct. Nutr. 2020, 1, 9. [Google Scholar] [CrossRef]
- Chen, L.; Wang, W.; Zhang, J.; Wang, W.; Ni, D.; Jiang, H. Dehydroascorbic acid affects the stability of catechins by forming conjunctions. Molecules 2020, 25, 4076. [Google Scholar] [CrossRef] [PubMed]
- Bi, W.; He, C.; Ma, Y.; Shen, J.; Zhang, L.H.; Peng, Y.; Xiao, P. Investigation of free amino acid, total phenolics, antioxidant activity and purine alkaloids to assess the health properties of non-Camellia tea. Acta Pharm. Sin. B 2016, 6, 170–181. [Google Scholar] [CrossRef] [Green Version]
- Castellana, F.; De Nucci, S.; De Pergola, G.; Di Chito, M.; Lisco, G.; Triggiani, V.; Sardone, R.; Zupo, R. Trends in coffee and tea consumption during the COVID-19 pandemic. Foods 2021, 10, 2458. [Google Scholar] [CrossRef]
- Namiki, K.; Wongsirisin, P.; Yokoyama, S.; Sato, M.; Rawangkan, A.; Sakai, R.; Iida, K.; Suganuma, M. (−)-Epigallocatechin gallate inhibits stemness and tumourigenicity stimulated by AXL receptor tyrosine kinase in human lung cancer cells. Sci. Rep. 2020, 10, 1–11. [Google Scholar] [CrossRef] [Green Version]
- Borra, S.K.; Mahendra, J.; Gurumurthy, P. Effect of curcumin against oxidation of biomolecules by hydroxyl radicals. J. Clin. Diagn. Res. JCDR 2014, 8, CC01. [Google Scholar] [CrossRef]
- Yang, C.S.; Wang, X.; Lu, G.; Picinich, S.C. Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 2009, 9, 429–439. [Google Scholar] [CrossRef] [Green Version]
- Butt, M.S.; Ahmad, R.S.; Sultan, M.T.; Qayyum, M.M.N.; Naz, A. Green tea and anticancer perspectives: Updates from last decade. Crit. Rev. Food Sci. Nutr. 2015, 55, 792–805. [Google Scholar] [CrossRef]
- Kochman, J.; Jakubczyk, K.; Antoniewicz, J.; Mruk, H.; Janda, K. Health benefits and chemical composition of matcha green tea: A review. Molecules 2020, 26, 85. [Google Scholar] [CrossRef]
- Reygaert, W.C. An update on the health benefits of green tea. Beverages 2017, 3, 6. [Google Scholar] [CrossRef] [Green Version]
- Musial, C.; Kuban-Jankowska, A.; Gorska-Ponikowska, M. Beneficial properties of green tea catechins. Int. J. Mol. Sci. 2020, 21, 1744. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pinto, G.; Illiano, A.; Carpentieri, A.; Spinelli, M.; Melchiorre, C.; Fontanarosa, C.; di Serio, M.; Amoresano, A. Quantification of polyphenols and metals in Chinese tea infusions by mass spectrometry. Foods 2020, 9, 835. [Google Scholar] [CrossRef] [PubMed]
- Khan, N.; Mukhtar, H. Tea polyphenols in promotion of human health. Nutrients 2019, 11, 39. [Google Scholar] [CrossRef] [Green Version]
- Shi, J.-F.; Chen, J.-F.; Canfell, K.; Feng, X.-X.; Ma, J.-F.; Zhang, Y.-Z.; Zhao, F.-H.; Li, R.; Ma, L.; Li, Z.-F. Estimation of the costs of cervical cancer screening, diagnosis and treatment in rural Shanxi Province, China: A micro-costing study. BMC Health Serv. Res. 2012, 12, 1–14. [Google Scholar] [CrossRef] [Green Version]
- Abe, S.K.; Inoue, M. Green tea and cancer and cardiometabolic diseases: A review of the current epidemiological evidence. Eur. J. Clin. Nutr. 2021, 75, 865–876. [Google Scholar] [CrossRef]
- Yiannakopoulou, E.C. Interaction of green tea catechins with breast cancer endocrine treatment: A systematic review. Pharmacology 2014, 94, 245–248. [Google Scholar] [CrossRef]
- Yang, C.S.; Lambert, J.D.; Sang, S. Antioxidative and anti-carcinogenic activities of tea polyphenols. Arch. Toxicol. 2009, 83, 11–21. [Google Scholar] [CrossRef] [Green Version]
- Yang, C.S.; Wang, X. Green tea and cancer prevention. Nutr. Cancer 2010, 62, 931–937. [Google Scholar] [CrossRef]
- Shirakami, Y.; Shimizu, M. Possible mechanisms of green tea and its constituents against cancer. Molecules 2018, 23, 2284. [Google Scholar] [CrossRef]
- Wang, X.-J.; Chen, J.-Y.; Fu, L.-Q.; Yan, M.-J. Recent advances in natural therapeutic approaches for the treatment of cancer. J. Chemother. 2020, 32, 53–65. [Google Scholar] [CrossRef] [PubMed]
- Fritz, H.; Seely, D.; Kennedy, D.A.; Fernandes, R.; Cooley, K.; Fergusson, D. Green tea and lung cancer: A systematic review. Integr. Cancer Ther. 2013, 12, 7–24. [Google Scholar] [CrossRef] [PubMed]
- Cheng, Z.; Zhang, Z.; Han, Y.; Wang, J.; Wang, Y.; Chen, X.; Shao, Y.; Cheng, Y.; Zhou, W.; Lu, X. A review on anti-cancer effect of green tea catechins. J. Funct. Foods 2020, 74, 104172. [Google Scholar] [CrossRef]
- Thangapazham, R.L.; Singh, A.K.; Sharma, A.; Warren, J.; Gaddipati, J.P.; Maheshwari, R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007, 245, 232–241. [Google Scholar] [CrossRef]
- Wu, A.H.; Butler, L.M. Green tea and breast cancer. Mol. Nutr. Food Res. 2011, 55, 921–930. [Google Scholar] [CrossRef] [PubMed]
- Fujiki, H.; Watanabe, T.; Sueoka, E.; Rawangkan, A.; Suganuma, M. Cancer prevention with green tea and its principal constituent, EGCG: From early investigations to current focus on human cancer stem cells. Mol. Cells 2018, 41, 73. [Google Scholar] [PubMed]
- Zhang, M.; Holman, C.D.A.J.; Huang, J.-p.; Xie, X. Green tea and the prevention of breast cancer: A case–control study in Southeast China. Carcinogenesis 2007, 28, 1074–1078. [Google Scholar] [CrossRef] [Green Version]
- Khan, N.; Bharali, D.J.; Adhami, V.M.; Siddiqui, I.A.; Cui, H.; Shabana, S.M.; Mousa, S.A.; Mukhtar, H. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis 2014, 35, 415–423. [Google Scholar] [CrossRef]
- Rawangkan, A.; Wongsirisin, P.; Namiki, K.; Iida, K.; Kobayashi, Y.; Shimizu, Y.; Fujiki, H.; Suganuma, M. Green tea catechin is an alternative immune checkpoint inhibitor that inhibits PD-L1 expression and lung tumor growth. Molecules 2018, 23, 2071. [Google Scholar] [CrossRef] [Green Version]
- Enkhbat, T.; Nishi, M.; Yoshikawa, K.; Jun, H.; Tokunaga, T.; Takasu, C.; Kashihara, H.; Ishikawa, D.; Tominaga, M.; Shimada, M. Epigallocatechin-3-gallate enhances radiation sensitivity in colorectal cancer cells through Nrf2 activation and autophagy. Anticancer. Res. 2018, 38, 6247–6252. [Google Scholar] [CrossRef]
- Khan, N.; Mukhtar, H. Modulation of signaling pathways in prostate cancer by green tea polyphenols. Biochem. Pharmacol. 2013, 85, 667–672. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sanna, V.; Singh, C.K.; Jashari, R.; Adhami, V.M.; Chamcheu, J.C.; Rady, I.; Sechi, M.; Mukhtar, H.; Siddiqui, I.A. Targeted nanoparticles encapsulating (−)-epigallocatechin-3-gallate for prostate cancer prevention and therapy. Sci. Rep. 2017, 7, 1–15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hou, I.-C.; Amarnani, S.; Chong, M.T.; Bishayee, A. Green tea and the risk of gastric cancer: Epidemiological evidence. World J. Gastroenterol. 2013, 19, 3713. [Google Scholar] [CrossRef] [PubMed]
- Teschke, R.; Schulze, J. Green tea and the question of reduced liver cancer risk: The dawn of potential clinical relevance? Hepatobiliary Surg. Nutr. 2017, 6, 122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hu, F.; Wei, F.; Wang, Y.; Wu, B.; Fang, Y.; Xiong, B. EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. J. Pharmacol. Sci. 2015, 128, 27–34. [Google Scholar] [CrossRef] [Green Version]
- Actor, J.K. Herbal Medicines with Immunomodulatory Effects. In Efficacy, Toxicity, Interactions with Western Drugs, and Effects on Clinical Laboratory Tests; John Wiley & Sons: Hoboken, NJ, USA, 2011; p. 75. [Google Scholar]
- Yuan, J.-M. Cancer prevention by green tea: Evidence from epidemiologic studies. Am. J. Clin. Nutr. 2013, 98, 1676S–1681S. [Google Scholar] [CrossRef] [Green Version]
- Yuan, J.M. Green tea and prevention of esophageal and lung cancers. Mol. Nutr. Food Res. 2011, 55, 886–904. [Google Scholar] [CrossRef]
- Zhong, L.; Goldberg, M.S.; Gao, Y.-T.; Hanley, J.A.; Parent, M.-É.; Jin, F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 2001, 12, 695–700. [Google Scholar] [CrossRef]
- Borrelli, F.; Capasso, R.; Russo, A.; Ernst, E. Green tea and gastrointestinal cancer risk. Aliment. Pharmacol. Ther. 2004, 19, 497–510. [Google Scholar] [CrossRef]
- Wang, S.-T.; Cui, W.-Q.; Pan, D.; Jiang, M.; Chang, B.; Sang, L.-X. Tea polyphenols and their chemopreventive and therapeutic effects on colorectal cancer. World J. Gastroenterol. 2020, 26, 562. [Google Scholar] [CrossRef]
- Suzuki, E.; Yorifuji, T.; Takao, S.; Komatsu, H.; Sugiyama, M.; Ohta, T.; Ishikawa-Takata, K.; Doi, H. Green tea consumption and mortality among Japanese elderly people: The prospective Shizuoka elderly cohort. Ann. Epidemiol. 2009, 19, 732–739. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Wang, X.-Q.; Zhang, Q.; Zhu, J.-Y.; Li, Y.; Xie, C.-F.; Li, X.-T.; Wu, J.-S.; Geng, S.-S.; Zhong, C.-Y. (−)-Epigallocatechin-3-gallate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway. Nutrients 2017, 9, 572. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, G.; Shu, X.-O.; Li, H.; Chow, W.-H.; Ji, B.-T.; Zhang, X.; Gao, Y.-T.; Zheng, W. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Prev. Biomark. 2007, 16, 1219–1223. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Russo, G.I.; Solinas, T.; Urzì, D.; Privitera, S.; Campisi, D.; Cocci, A.; Carini, M.; Madonia, M.; Cimino, S.; Morgia, G. Adherence to Mediterranean diet and prostate cancer risk in Sicily: Population-based case–control study. Int. J. Impot. Res. 2019, 31, 269–275. [Google Scholar] [CrossRef]
- Miyata, Y.; Shida, Y.; Hakariya, T.; Sakai, H. Anti-cancer effects of green tea polyphenols against prostate cancer. Molecules 2019, 24, 193. [Google Scholar] [CrossRef] [Green Version]
- Huang, Y.; Chen, H.; Zhou, L.; Li, G.; Yi, D.; Zhang, Y.; Wu, Y.; Liu, X.; Wu, X.; Song, Q. Association between green tea intake and risk of gastric cancer: A systematic review and dose–response meta-analysis of observational studies. Public Health Nutr. 2017, 20, 3183–3192. [Google Scholar] [CrossRef] [Green Version]
- Hoshiyama, Y.; Kawaguchi, T.; Miura, Y.; Mizoue, T.; Tokui, N.; Yatsuya, H.; Sakata, K.; Kondo, T.; Kikuchi, S.; Toyoshima, H. Green tea and stomach cancer--a short review of prospective studies. J. Epidemiol. 2005, 15, S109–S112. [Google Scholar] [CrossRef] [Green Version]
- Jin, X.; Zheng, R.h.; Li, Y.m. Green tea consumption and liver disease: A systematic review. Liver Int. 2008, 28, 990–996. [Google Scholar] [CrossRef]
- Mu, L.; Zhou, X.; Ding, B.; Wang, R.; Zhang, Z.; Jiang, Q.; Yu, S. Study on the protective effect of green tea on gastric, liver and esophageal cancers. Zhonghua Yu Fang Yi Xue Za Zhi (Chin. J. Prev. Med.) 2003, 37, 171–173. [Google Scholar]
- Sharma, P.; Montes de Oca, M.K.; Alkeswani, A.R.; McClees, S.F.; Das, T.; Elmets, C.A.; Afaq, F. Tea polyphenols for the prevention of UVB-induced skin cancer. Photodermatol. Photoimmunol. Photomed. 2018, 34, 50–59. [Google Scholar] [CrossRef] [Green Version]
- Nichols, J.A.; Katiyar, S.K. Skin photoprotection by natural polyphenols: Anti-inflammatory, antioxidant and DNA repair mechanisms. Arch. Dermatol. Res. 2010, 302, 71–83. [Google Scholar] [CrossRef] [PubMed]
- Shankar, S.; Ganapathy, S.; Hingorani, S.R.; Srivastava, R.K. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front. Biosci. 2008, 13, 440–452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lin, Y.; Kikuchi, S.; Tamakoshi, A.; Yagyu, K.; Obata, Y.; Kurosawa, M.; Inaba, Y.; Kawamura, T.; Motohashi, Y.; Ishibashi, T. Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas 2008, 37, 25–30. [Google Scholar] [CrossRef] [PubMed]
- Luo, J.; Inoue, M.; Iwasaki, M.; Sasazuki, S.; Otani, T.; Ye, W.; Tsugane, S.; Group, J.S. Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur. J. Cancer Prev. 2007, 16, 542–548. [Google Scholar] [CrossRef]
- Liao, S.; Tang, Y.; Chu, C.; Lu, W.; Baligen, B.; Man, Y.; Qu, Y. Application of green tea extracts epigallocatechin-3-gallate in dental materials: Recent progress and perspectives. J. Biomed. Mater. Res. A 2020, 108, 2395–2408. [Google Scholar] [CrossRef]
- Lee, A.H.; Fraser, M.L.; Binns, C.W. Possible role for green tea in ovarian cancer prevention. Future Oncol. 2005, 1, 771–777. [Google Scholar] [CrossRef] [Green Version]
- Nagle, C.M.; Olsen, C.M.; Bain, C.J.; Whiteman, D.C.; Green, A.C.; Webb, P.M. Tea consumption and risk of ovarian cancer. Cancer Causes Control 2010, 21, 1485–1491. [Google Scholar] [CrossRef]
- Trudel, D.; Labbé, D.P.; Bairati, I.; Fradet, V.; Bazinet, L.; Têtu, B. Green tea for ovarian cancer prevention and treatment: A systematic review of the in vitro, in vivo and epidemiological studies. Gynecol. Oncol. 2012, 126, 491–498. [Google Scholar] [CrossRef]
- Zhang, M.; Lee, A.H.; Binns, C.W.; Xie, X. Green tea consumption enhances survival of epithelial ovarian cancer. Int. J. Cancer 2004, 112, 465–469. [Google Scholar] [CrossRef]
- Miyata, Y.; Matsuo, T.; Araki, K.; Nakamura, Y.; Sagara, Y.; Ohba, K.; Sakai, H. Anticancer effects of green tea and the underlying molecular mechanisms in bladder cancer. Medicina 2018, 5, 87. [Google Scholar] [CrossRef] [Green Version]
- Leppert, J.T.; Shvarts, O.; Kawaoka, K.; Lieberman, R.; Belldegrun, A.S.; Pantuck, A.J. Prevention of bladder cancer: A review. Eur. Urol. 2006, 49, 226–234. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.-Y.; Chen, Y.-J.; Chang, W.-A.; Li, W.-M.; Ke, H.-L.; Wu, W.-J.; Kuo, P.-L. Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma―Next-Generation Sequencing and Bioinformatics Approaches. Medicina 2019, 55, 768. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, L.-X.; Shi, Y.-L.; Zhang, L.-J.; Wang, K.-R.; Xiang, L.-P.; Cai, Z.-Y.; Lu, J.-L.; Ye, J.-H.; Liang, Y.-R.; Zheng, X.-Q. Inhibitory effects of (−)-epigallocatechin-3-gallate on esophageal cancer. Molecules 2019, 24, 954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Steele, V.E.; Kelloff, G.J.; Balentine, D.; Boone, C.W.; Mehta, R.; Bagheri, D.; Sigman, C.C.; Zhu, S.; Sharma, S. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 2000, 21, 63–67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, J.; Wu, X.; Kamat, A.; Grossman, H.B.; Dinney, C.; Lin, J. Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk. Br. J. Cancer 2013, 108, 2372–2380. [Google Scholar] [CrossRef] [Green Version]
- Lubin, J.H.; De Stefani, E.; Abnet, C.C.; Acosta, G.; Boffetta, P.; Victora, C.; Graubard, B.I.; Muñoz, N.; Deneo-Pellegrini, H.; Franceschi, S. Mate drinking and esophageal squamous cell carcinoma in South America: Pooled results from two large multicenter case–control studies. Cancer Epidemiol. Prev. Biomark. 2014, 23, 107–116. [Google Scholar] [CrossRef] [Green Version]
- Wang, Z.; Tang, L.; Sun, G.; Tang, Y.; Xie, Y.; Wang, S.; Hu, X.; Gao, W.; Cox, S.B.; Wang, J.-S. Etiological study of esophageal squamous cell carcinoma in an endemic region: A population-based case control study in Huaian, China. BMC Cancer 2006, 6, 1–9. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y. Epidemiology of esophageal cancer. World J. Gastroenterol. 2013, 19, 5598. [Google Scholar] [CrossRef]
- Kamangar, F.; Freedman, N.D. Hot tea and esophageal cancer. Ann. Intern. Med. 2018, 168, 519–520. [Google Scholar] [CrossRef]
- Lin, S.; Xu, G.; Chen, Z.; Liu, X.; Li, J.; Ma, L.; Wang, X. Tea drinking and the risk of esophageal cancer: Focus on tea type and drinking temperature. Eur. J. Cancer Prev. 2020, 29, 382–387. [Google Scholar] [CrossRef]
- Kurahashi, N.; Sasazuki, S.; Iwasaki, M.; Inoue, M.; Group, S.T.f.t.J.S. Green tea consumption and prostate cancer risk in Japanese men: A prospective study. Am. J. Epidemiol. 2008, 167, 71–77. [Google Scholar] [CrossRef] [PubMed]
- Zheng, J.; Yang, B.; Huang, T.; Yu, Y.; Yang, J.; Li, D. Green tea and black tea consumption and prostate cancer risk: An exploratory meta-analysis of observational studies. Nutr. Cancer 2011, 63, 663–672. [Google Scholar] [CrossRef]
- Tavani, A.; Bertuzzi, M.; Talamini, R.; Gallus, S.; Parpinel, M.; Franceschi, S.; Levi, F.; La Vecchia, C. Coffee and tea intake and risk of oral, pharyngeal and esophageal cancer. Oral Oncol. 2003, 39, 695–700. [Google Scholar] [CrossRef]
- Gan, R.-Y.; Li, H.-B.; Sui, Z.-Q.; Corke, H. Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review. Crit. Rev. Food Sci. Nutr. 2018, 58, 924–941. [Google Scholar] [CrossRef] [PubMed]
- Zhu, M.-z.; Lu, D.-m.; Ouyang, J.; Zhou, F.; Huang, P.-f.; Gu, B.-z.; Tang, J.-w.; Shen, F.; Li, J.-f.; Li, Y.-l.; et al. Tea consumption and colorectal cancer risk: A meta-analysis of prospective cohort studies. Eur. J. Nutr. 2020, 59, 3603–3615. [Google Scholar] [CrossRef]
Name of the Constituents | Quantity (%) |
---|---|
Protein | 15–20 |
Amino acids | 1–4 |
Carbohydrates | 5–7 |
Essential trace elements | 5 |
Catechins | 20–30 |
Lignin | 7 |
Organic acid | 2 |
Chlorophyll | 0.5 |
Organ Sites | Green Tea Consumption Level | Country of the Study Conducted | Gender | Population Size | Results Found | References |
---|---|---|---|---|---|---|
Breast | ≥5 cups/day ≤4 cups/day | Japan | Men and women | 8552 | High consumption level showed lower risk | [36] |
Lung | n/a | China | Women | 675 | Consumption of green tea associated with reduced lung cancer risk | [32,49] |
Colon-rectum | >5 cups/day | China | Men and women | >60,000 | Insignificant increase in risk of colon cancer in regular drinkers than non-drinkers. | [47] |
Prostate | ≥5 cups/day ≤1 cup/day | Japan | Men | 49,920 | Green tea consumption may be associated with a reduced risk of prostate cancer | [47,82] |
Stomach | ≥5 cups/day ≥7 cups/day | Japan | Men | 39,290 | Greater consumption showed better result | [83] |
Liver | ≥5 cups/day 1 cup/day | Japan | Men and women | 21,128 | Greater intake possessed lesser risk | [44] |
Skin | n/a | No dose-related result was found | ||||
Pancreas | ≥7 cups/day <1 cup/day | Japan | Men and women | 100,000 | No association between green tea consumption and cancer risk was found | [3] |
Oral | ≥5 cups/day ≤1 cup/day | Japan | Men and women | 50,221 | An inverse relation between green tea consumption and oral cancer | [47,84] |
Ovary | ≥4 cups/day | Australia | Men and women | 2784 | Significant reduction in ovary cancer risk with green tea intake | [69] |
Bladder | ≥5 cups/day | Canada | Men and women | 3045 | associated with green tea consumption. | [3] |
Esophagus | ≥300 g/month | China | Men and women | 1884 | Moderate level of consumption may reduce the risk but drinking tea > 65 °C has association with increased cancer risk | [81] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Trisha, A.T.; Shakil, M.H.; Talukdar, S.; Rovina, K.; Huda, N.; Zzaman, W. Tea Polyphenols and Their Preventive Measures against Cancer: Current Trends and Directions. Foods 2022, 11, 3349. https://doi.org/10.3390/foods11213349
Trisha AT, Shakil MH, Talukdar S, Rovina K, Huda N, Zzaman W. Tea Polyphenols and Their Preventive Measures against Cancer: Current Trends and Directions. Foods. 2022; 11(21):3349. https://doi.org/10.3390/foods11213349
Chicago/Turabian StyleTrisha, Anuva Talukder, Mynul Hasan Shakil, Suvro Talukdar, Kobun Rovina, Nurul Huda, and Wahidu Zzaman. 2022. "Tea Polyphenols and Their Preventive Measures against Cancer: Current Trends and Directions" Foods 11, no. 21: 3349. https://doi.org/10.3390/foods11213349
APA StyleTrisha, A. T., Shakil, M. H., Talukdar, S., Rovina, K., Huda, N., & Zzaman, W. (2022). Tea Polyphenols and Their Preventive Measures against Cancer: Current Trends and Directions. Foods, 11(21), 3349. https://doi.org/10.3390/foods11213349